Compounds and methods for treating dyslipidemia

Details for Australian Patent Application No. 2005267436 (hide)

Owner Eli Lilly and Company

Inventors Wang, Xiaodong; Mantlo, Nathan, Bryan; Fernandez, Maria, Carmen; De La Nava, Eva, Maria; Mateo-Herranz, Ana, Isabel; Escribano, Ana, Maria

Agent Spruson & Ferguson

Pub. Number AU-A-2005267436

PCT Pub. Number WO2006/012093

Priority 60/582,708 24.06.04 US; 60/664,862 24.03.05 US; 60/627,241 12.11.04 US

Filing date 22 June 2005

Wipo publication date 2 February 2006

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

21 December 2006 PCT application entered the National Phase

  PCT publication WO2006/012093 Priority application(s): WO2006/012093

2 July 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005267438-Hydrocarbon refrigerant compositions and uses thereof

2005267432-Energy storage system and method for hybrid propulsion